Identification of clinical diagnostic and immune cell infiltration characteristics of acute myocardial infarction with machine learning approach.

Journal: Scientific reports
Published Date:

Abstract

Acute myocardial infarction (AMI) is a serious heart disease with high fatality rates. The progress of AMI involves immune cell infiltration. However, suitable clinical diagnostic biomarkers and the roles of immune cells in AMI remain unknown. Three datasets (GSE61145, GSE34198, and GSE66360) were used from Gene Expression Omnibus. Dysregulated expression of genes was screened and functionally analyzed. Weighted Gene Co-expression Network Analysis (WGCNA) was used to identify significant module genes associated with AMI. Machine learning algorithms (Support Vector Machine (SVM), Random Forest (RF) and Least Absolute Shrinkage and Selection Operator (LASSO)) were applied to identify hub genes. Subsequently, receiver operating characteristic curves (ROC) were generated to evaluate the risk of AMI patients. Finally, immune cell infiltration were assessed by CIBERSORT, correlation analysis and immunohistochemistry. A total of 134 upregulated and 25 downregulated genes were identified. Functional analysis showed that the dysregulated genes were involved in cytokine- and immune-related signaling. Ten hub genes were used to establish a diagnostic model. Immune cell infiltration analysis showed that ten genes were correlated with activation of various immune cells; specifically, naive B cells, activated CD4 memory T cells, and resting mast cells were significantly associated with AMI. Immunohistochemical staining indicated that FOS and IL18RAP were significantly upregulated in AMI, CD4 naive T and neutrophils were significantly infiltrated in the microenvironment of AMI. The hub genes involved in activating immune cell infiltration and developing AMI could act as promising diagnostic biomarkers and targets for clinical treatment of AMI.

Authors

  • Huali Jiang
    School of Opto-Electronic and Communication Engineering, Xiamen University of Technology, Xiamen, China.
  • Weijie Chen
  • Benfa Chen
    Department of Cardiovascularology, Dongguan Key Laboratory of Prevention and Treatment for Chronic Cardiovascular Diseases, Dongguan Tungwah Hospital, Dongguan, China.
  • Tao Feng
    School of Pharmacy, Anhui University of Chinese Medicine, Anhui Key Laboratory of Modern Chinese Materia Medica Hefei 230012 People's Republic of China tfeng@mail.scuec.edu.cn wanggk@ahtcm.edu.cn.
  • Heng Li
    Department of Anesthesiology, Affiliated Nanhua Hospital, University of South China, Hengyang 421002, Hunan Province, China.
  • Dan Li
    State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, PR China.
  • Shanhua Wang
    Department of Cardiovascularology, Dongguan Key Laboratory of Prevention and Treatment for Chronic Cardiovascular Diseases, Dongguan Tungwah Hospital, Dongguan, China. 2659259772@qq.com.
  • Weijie Li
    Communication and Network Laboratory, Dalian University, Dalian 116622, China.